Enzyme
Activity Assays

GLP and GMP-certified enzyme activity evaluations engineered for natural and synthetic enzymes, enzymatic biomarkers, and targeted inhibitors across complex formulations.

Therapeutic EnzymesEnzyme InhibitorsEnzyme Kinetics

Pioneering Enzymatic Characterization

BrownBiology Laboratory delivers high-end enzymatic activity assays strictly governed under GLP/GMP conditions spanning both bioanalytical and comprehensive CMC projects.

By harmonizing deeply specialized scientific expertise with extensive regulatory intelligence, we guarantee statistically reliable, completely validated analytical outputs applicable to robust biological and pharmaceutical formulations.

Our Dedicated Methodology

We define precise enzyme activity by introducing targeted synthetic substrates and longitudinally measuring subsequent product generation and turnover velocity using highly calibrated microtiter plate analytical suites.

  • 鉁?/span>Advanced Kinetic measurements of micro-enzymatic expressions
  • 鉁?/span>Enzyme-substrate specificity interaction analyses
  • 鉁?/span>Inhibitor efficacy and reversibility screening arrays
  • 鉁?/span>Absorbance, luminescence, or fluorescence detections
Connect With Scientists
Biological validation setup

Bioanalysis by Enzymatic Activity

We oversee full GLP-validated enzymatic activity tracking across highly variable biological matrices driving preclinical and clinical milestones. This sophisticated methodology is seamlessly derived from progressive EMA Immunological guidelines.

Endpoint Measurements

The primary enzymatic reaction is terminated after an exact time period.

Real-time Kinetics

The complete enzymatic sequence is continuously monitored per strict time unit.

CMC of Enzyme-Based Drugs & QC Assays

Our facility supplies uncompromising GMP-certified Quality Control networks alongside integrated CMC portfolios curated for enzyme-based therapeutics and molecular inhibitors.

  • Bioassay and biological potency indexing
  • Extensive stability surveillance operating under strict ICH conditions
  • Manufacturing batch release testing sequences

All downstream analytical testing aligns directly with global Pharmacopoeial configurations (Ph. Eur., USP) minimizing submission friction.

Broad Range of Enzyme Portfolios

Our teams maintain mature infrastructure required to handle robust activity assays transversing highly complex biomolecules.

1Proteases

Deep profiling spanning specialized proteins including functional variants of trypsin, specific pepsin formats, serine proteases, and targeted carboxypeptidase constructs.

2Lipases & Esterases

Robust analysis structures supporting metabolic profiling and formulation verification (e.g. phospholipase integrity, colipase functions, complex cholesterol esterases).

3Glycosidases

Extensive kinetic capability tracking and validating broad-spectrum hydrolase activity networks encompassing standard amylase, localized lysozymes, target cellulase, and lactase matrices.

Why Trust BrownBiology?

Regulatory Excellence

Our enzyme activity testing complies with ICH guidelines and is validated under GLP or GMP conditions to support global regulatory submissions (EMA, FDA, etc.).

Fast Turnaround & Flexibility

We offer rapid timelines, deeply personalized services, and highly proactive communication to keep your analytical project on track and accelerate your time-to-market.

Bioanalysis & CMC Expertise

BrownBiology uniquely integrates both GLP bioanalytical services and GMP CMC testing, enabling comprehensive project support across the entire drug development lifecycle.

Custom Method Development

We pioneer fit-for-purpose enzyme activity assays, skillfully adapting complex analytical approaches to specific molecule properties and exacting regulatory demands.

Need Actionable Kinetic Data?

Bring molecular predictability to your innovative therapeutics. Whether you require robust protease screenings, specialized lipase baselines, or customized inhibitor evaluations.

Request a Project Proposal